279 related articles for article (PubMed ID: 9501412)
1. Mixed-type autoimmune hemolytic anemia following fludarabine treatment in a patient with chronic lymphocytic leukemia/small cell lymphoma.
Vick DJ; Byrd JC; Beal CL; Chaffin DJ
Vox Sang; 1998; 74(2):122-6. PubMed ID: 9501412
[TBL] [Abstract][Full Text] [Related]
2. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
[TBL] [Abstract][Full Text] [Related]
3. Autologous CD34+ cells transplantation after FAMP treatment in a patient with CLL and persisting AIHA: complete remission of lymphoma with control of autoimmune complications.
Jindra P; Koza V; Fiser J; Vozobulová V; Svojgrová M
Bone Marrow Transplant; 1999 Jul; 24(2):215-7. PubMed ID: 10455354
[TBL] [Abstract][Full Text] [Related]
4. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
[TBL] [Abstract][Full Text] [Related]
5. Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia.
Tsiara S; Christou L; Konstantinidou P; Panteli A; Briasoulis E; Bourantas KL
Am J Hematol; 1997 Apr; 54(4):342. PubMed ID: 9092698
[No Abstract] [Full Text] [Related]
6. [Autoimmune hemolytic anemia, complement-mediated by warm reactive antibodies, associated with lymphoma].
Gallurt P; Oyonarte S; Gil JL; Senra A; Millán J
Rev Clin Esp; 1988 Nov; 183(7):383. PubMed ID: 3062716
[No Abstract] [Full Text] [Related]
7. Severe autoimmune hemolytic anemia in eight patients treated with fludarabine.
Gonzalez H; Leblond V; Azar N; Sutton L; Gabarre J; Binet JL; Vernant JP; Dighiero G
Hematol Cell Ther; 1998 Jun; 40(3):113-8. PubMed ID: 9698219
[TBL] [Abstract][Full Text] [Related]
8. Fludarabine induced autoimmune haemolytic anaemia in a patient with chronic lymphocytic leukaemia.
Syed NN; Khurshid M
J Pak Med Assoc; 2006 Jan; 56(1):44-5. PubMed ID: 16454137
[TBL] [Abstract][Full Text] [Related]
9. Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient population.
Perkins JG; Flynn JM; Howard RS; Byrd JC
Cancer; 2002 Apr; 94(7):2033-9. PubMed ID: 11932906
[TBL] [Abstract][Full Text] [Related]
10. Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab.
Swords R; Nolan A; Fay M; Quinn J; O'Donnell R; Murphy PT
Clin Lab Haematol; 2006 Feb; 28(1):57-9. PubMed ID: 16430461
[TBL] [Abstract][Full Text] [Related]
11. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
[TBL] [Abstract][Full Text] [Related]
12. Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia.
Tertian G; Cartron J; Bayle C; Rudent A; Lambert T; Tchernia G
Hematol Cell Ther; 1996 Aug; 38(4):359-60. PubMed ID: 8891729
[TBL] [Abstract][Full Text] [Related]
13. The Scripps Clinic experience with cladribine (2-CdA) in the treatment of chronic lymphocytic leukemia.
Saven A
Semin Hematol; 1996 Jan; 33(1 Suppl 1):28-33. PubMed ID: 8714614
[No Abstract] [Full Text] [Related]
14. Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice?
Smolej L
Leuk Res; 2007 Feb; 31(2):267; author reply 268-9. PubMed ID: 16716397
[No Abstract] [Full Text] [Related]
15. [Fludarabine and fatal hemolytic anemia].
López L; del Villar V; Pascual T
Sangre (Barc); 1995 Aug; 40(4):335-6. PubMed ID: 7482124
[No Abstract] [Full Text] [Related]
16. The effect of fludarabine on interferon-gamma production by lymphoid cells from healthy donors and patients with B-cell chronic lymphocytic leukemia.
Gamberale R; Fernández-Calotti P; Sánchez-Avalos J; Alberto MF; Geffner J; Giordano M
Haematologica; 2006 Apr; 91(4):574-6. PubMed ID: 16533725
[TBL] [Abstract][Full Text] [Related]
17. The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia.
Pamuk GE; Turgut B; Demir M; Tezcan F; Vural O
Am J Hematol; 2006 Aug; 81(8):631-3. PubMed ID: 16906592
[TBL] [Abstract][Full Text] [Related]
18. [Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome].
Takei K; Horikoshi A; Hosokawa Y; Sawada S; Horie T
Rinsho Ketsueki; 2002 Nov; 43(11):993-7. PubMed ID: 12508485
[TBL] [Abstract][Full Text] [Related]
19. Early-onset autoimmune hemolytic anemia after cladribine therapy for Waldenström's macroglobulinemia.
Aslan DL; Peterson BA; Long-Tsai M; Eastlund T
Transfusion; 2006 Jan; 46(1):90-4. PubMed ID: 16398735
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.
Diehl LF; Ketchum LH
Semin Oncol; 1998 Feb; 25(1):80-97. PubMed ID: 9482530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
